Advertisement

Bipolar Disorder

  • Alan J. Gelenberg
  • Stephen C. Schoonover

Abstract

Lithium (Eskalith® and others), a naturally occurring salt, has been used for various medical purposes since the 1800s. Initially, it was given to patients who suffered from urinary calculi and gout. Later, it was combined with bromides and used as a sedative. In 1949, Cade observed that lithium calmed agitated psychotic patients: ten manic patients responded, six schizophrenic and chronically depressed psychotic patients did not, and one patient’s symptoms reappeared after lithium was stopped.1 During this same period, lithium was introduced in the United States as a salt substitute for cardiac patients, but it caused numerous toxic reactions and several deaths. Thus, even with the emergence of convincing evidence that lithium was safe and effective in manic depressive illness, it was not accepted in the United States until 1970.

Keywords

Bipolar Disorder Mood Disorder Antipsychotic Drug Neuroleptic Malignant Syndrome Antipsychotic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cade J. F. J.: Lithium salts in the treatment of psychotic excitement. Med J Aust 11:349–352, 1949.Google Scholar
  2. 2.
    Davis J. M.: Overview: Maintenance therapy in psychiatry: II. Affective disorders. Am J Psychiatry 133:1–13, 1976.PubMedGoogle Scholar
  3. 3.
    Forn J., Valdecasas F. G.: Effects of lithium on brain adenyl cyclate activity. Biochem Pharmacol 20:2773–2779, 1971.PubMedCrossRefGoogle Scholar
  4. 4.
    Gjessing L. R.: Lithium citrate loading of a patient with periodic catatonia. Acta Psychiatr Scand 43:372–375, 1967.PubMedCrossRefGoogle Scholar
  5. 5.
    Kline N. S., Wren J. C., Cooper T. B., et al: Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268:15–22, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Rifkin A., Quitkin F., Carrillo R., et al: Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry 27:519–522, 1972.PubMedCrossRefGoogle Scholar
  7. 7.
    Gottfries C. G.: The effect of lithium salts on various kinds of psychiatric disorders. Acta Psychiatr Scand [Suppl] 203:157–167, 1968.CrossRefGoogle Scholar
  8. 8.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised (DSM-IIIR). Washington, American Psychiatric Association, 1987.Google Scholar
  9. 9.
    Nurnberger J R., Roose S. P., Dunner D. L., et al: Unipolar mania: A distinct clinical entity? Am J Psychiatry 136:1420–1423, 1979.PubMedGoogle Scholar
  10. 10.
    Keller M. B., Lavori P. W., Coryell W., et al.: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3138–3142, 1986.PubMedCrossRefGoogle Scholar
  11. 11.
    Winokur G., Clayton P. J., Reich T.: Manic Depressive Disease. St. Louis, C. V. Mosby, 1969.Google Scholar
  12. 12.
    Weissman M. M., Leaf P. J., Livingston B. M., et al.: The epidemiology of dysthymia in the community: Rates, risks, comorbidity and treatment. 140th Annual Meeting of the American Psychiatric Association, Chicago, American Psychiatric Association, 1987.Google Scholar
  13. 13.
    Medical Practice Project: A State-of-the-Science Report for the Office of the Assistant Secretary for the U. S. Department of Health, Education and Welfare. Baltimore, Policy Research, 1979.Google Scholar
  14. 14.
    Fieve R. R.: The lithium clinic: A new model for the delivery of psychiatric services. Am. J Psychiatry 132:1018–1022, 1975.PubMedGoogle Scholar
  15. 15.
    Garfinkel P. E., Stancer H. C., Persad E.: A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 2:279–288, 1980.CrossRefGoogle Scholar
  16. 16.
    Prien R. F., Caffey E. M. Jr, Klett C. J.: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 26:146–152, 1972.PubMedCrossRefGoogle Scholar
  17. 17.
    Fieve R. R.: Overview of therapeutic and prophylactic trials with lithium in psychiatric patients, in Gershon S., Shopsin B. (eds): Lithium. Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, p 336.Google Scholar
  18. 18.
    VanPutten T.: Why do patients with manic-depressive illness stop their lithium? Compr Psychiatry 16:179–183, 1975.PubMedCrossRefGoogle Scholar
  19. 19.
    Cooper T. B.: Pharmacokinetics of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1365–1376.Google Scholar
  20. 20.
    Schou M., Anderson A., Eskajaer-Jensen S., et al .: Occurrence of goiter during lithium treatment. Br J Med 3:710–713, 1968.CrossRefGoogle Scholar
  21. 21.
    Emerson C. H., Dyson W. L., Utiger R. D.: Serum thyrotropin and thyroxin concentration in patients receiving lithium carbonate. J Clin Endocrinol Metab 36:338–346, 1973.PubMedCrossRefGoogle Scholar
  22. 22.
    Jefferson J. W.: Lithium carbonate-induced hypothyroidism-its many faces. JAMA 242:271–272, 1979.PubMedCrossRefGoogle Scholar
  23. 23.
    VanderVelde C. D., Gordon M. W.: Manic-depressive illness, diabetes mellitus and lithium carbonate treatment. Arch Gen Psychiatry 21:478–485, 1969.PubMedCrossRefGoogle Scholar
  24. 24.
    Mellerup E. T., Plenge P., Rafaelson O. J. : Renal and other controversial adverse effects of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1443–1448.Google Scholar
  25. 25.
    Gelenberg A. J.: Lithium-induced polyuria: Approaches to management. Biol Ther Psychiatry Newslett 6:17–19, 1983.Google Scholar
  26. 26.
    Gelenberg A. J., Wojcik J. D., Falk W. E., et al: Effects of lithium on the kidney. Acta Psychiatr Scand 75:29–34, 1987.PubMedCrossRefGoogle Scholar
  27. 27.
    Gelenberg A. J.: Lithium and the nephrotic syndrome. Biol Ther Psychiatry 12:24, 1989.Google Scholar
  28. 28.
    Shopsin B., Gershon S.: Pharmacology-toxicology of the lithium ion, in Gershon S., Shopsin B. (eds): Lithium: Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, pp 107–146.Google Scholar
  29. 29.
    Schou M.: Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type. Acta Psychiatr Scand [Suppl] 169:258–259, 1963.CrossRefGoogle Scholar
  30. 30.
    Roose S. P., Nurnberger J. L., Dunner D. L., et al: Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 136:804–806, 1979.PubMedGoogle Scholar
  31. 31.
    Jaffe C. M.: First-degree atrioventricular block during lithium carbonate treatment. Am J Psychiatry 134:88–89, 1977.PubMedGoogle Scholar
  32. 32.
    Worthley L. J. C.: Lithium toxicity and refractory cardiac arrhythmia treated with intravenous magnesium. Anesth Intens Care 2:357–360, 1974.Google Scholar
  33. 33.
    Jefferson J. W., Greist J. H. : Adverse reactions—neurological tremor, in Jefferson, J. W., Greist, J. H. (eds): Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977, pp 139–150.Google Scholar
  34. 34.
    Ghandirian A. M., Lehman H. E.: Neurological side effects of lithium: Organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 21:327–335, 1980.CrossRefGoogle Scholar
  35. 35.
    Vestergaard P., Amdison A., Schou M.: Clinically significant side effects of lithium treatment: A survey of 237 patients in long-term treatment. Acta Psychiatr Scand 62:193–200, 1980.PubMedCrossRefGoogle Scholar
  36. 36.
    Schou M.: Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70:594–602, 1984.PubMedCrossRefGoogle Scholar
  37. 37.
    Gelenberg A. J., Kane J. M., Keller M. B., Lavori P., Rosenbaum J. F., Cole K., Lavelle J.: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489–1493, 1989.PubMedCrossRefGoogle Scholar
  38. 38.
    Donaldson S. R., Gelenberg A. J., Baldessarini R. J.: The pharmacologic treatment of schizophrenia: A progress report. Schizophrenia Bull 9:504–527, 1983.CrossRefGoogle Scholar
  39. 39.
    Prien R. F., Gelenberg A. J.: Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 146:840–848, 1989.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Alan J. Gelenberg
    • 1
  • Stephen C. Schoonover
    • 2
  1. 1.Department of PsychiatryUniversity of Arizona Health Sciences CenterTucsonUSA
  2. 2.Newton CentreSchoonover AssociatesUSA

Personalised recommendations